BPI 2026 · CDMO & CRO

Bora Biologics at BPI 2026

Bora Biologics brings 3 presentations to BPI 2026 in Boston, and exhibits at Booth 836. Its sessions cover CHO cell line development and CMC lessons from technology transfer. One compares site-specific and transposon-based integration platforms, and another offers a practical workflow for assessing glass vial performance in drug product development.

OrganizationBPI 2026 Attendance
1 Vice President, Manufacturing · 1 Associate Director, Cell Line and Cell Culture Process Development · 1 Scientist I
borabiologics.com
CDMO & CROPlatinum sponsor
U.S.-based biologics CDMO specializing in late-stage and commercial GMP manufacturing on mammalian and microbial platforms.
Booth
Exhibiting at Booth 836
Wed, Sep 233:30pm–7:00pmThu, Sep 248:15am–5:00pmFri, Sep 259:00am–1:50pm
Talk
Thu Sep 24
11:30am–12:00pm
KEYNOTE: Lessons from Global Leadership in CMC, Technology Transfer, and Manufacturing
CMC Strategy & Manufacturing Performance
Talk
Thu Sep 24
12:30pm–1:00pm
Advancing CHO Cell Line Development: A Dual-Strategy Approach Using Site-Specific and Transposon-Based Integration Platforms
Cell Line Development & Engineering
Talk
Fri Sep 25
11:15am–11:45am
A Practical Workflow for Assessing Glass Vial Performance in Drug Product Development
CMC Strategy & Manufacturing Performance

Explore the full BPI 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Boston. Leave your work email and we’ll be in touch.

Privacy

Download the full BPI 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Bora Biologics

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by Informa Connect or the BioProcess International Conference & Exhibition. Submit a correction